NCT03377582

Brief Summary

The aim of this study is to investigate engagement, motivation, and the barriers to adherence of virtual reality based therapy (VRBT) in patients with cardiac diseases and risk factors to the development of cardiac diseases. In addition, to investigate autonomic and hemodynamic responses of VRBT in comparison with conventional therapy (CT). To do this, patients with cardiac diseases or risk factors will be invited to perform CT or VRBT+CT. They will be submitted to an initial evaluation, and then will be random allocated to 12 weeks of intervention and to a final evaluation. The primary outcomes includes engagement, motivation, barriers and adherence in the 12 previous weeks using questionnaire, after 12 weeks of the intervention and after 12 weeks of the final intervention program. Hemodynamic and autonomic responses will be considered the secondary outcomes being evaluated before, during and after a session at the first, sixth and twelfth week.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 19, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

December 19, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 3, 2019

Completed
Last Updated

August 5, 2019

Status Verified

August 1, 2019

Enrollment Period

12 months

First QC Date

November 6, 2017

Last Update Submit

August 2, 2019

Conditions

Keywords

cardiovascular diseasescardiac rehabilitationsympathetic nervous systemheart rateblood pressureclinical trialvirtual reality exposure therapybarriers to cardiac rehabilitationmotivationadherence patientengagementperceived exertionoxygen saturation

Outcome Measures

Primary Outcomes (4)

  • Engagement

    Measured using the Utrecht engagement scale modified There is 17 items scored from 1 to 7, according to the Likert Scale. Then, each item is summed and divided for the number of items. Higher values represent a better engagement.

    Change from baseline at 12 weeks

  • Motivation

    Measured using the Intrinsic motivation inventory There is 18 items scored from 1 to 5, according to the Likert Scale. Then, each item is summed and divided for the number of items. Higher values represent a better motivation.

    Change from baseline at 12 weeks

  • Barriers to Cardiac Rehabilitation

    Measured using Cardiac Rehabilitation Barriers Scale There is 21 items score from 1 to 5, according to the Likert Scale. Then, each item is summed and divided for the number of items. Higher values represent a worse outcome. In addition, there is four subscales: 1) Perceived need/health care factors, 2) Logistical factors, 3) Work/time conflicts, and 4) Comorbidities/functional status. The subscales are scored in the same way of the total, it means, from 1 to 5 and them dividing from the total number of the items included in the subscale.

    Change from baseline at 12 weeks

  • Adherence to Cardiac Rehabilitation

    Measured using the number of cardiac rehabilitation sessions attended

    Change from baseline at 12 weeks

Secondary Outcomes (6)

  • Autonomic responses

    Up to 12 weeks

  • Blood pressure

    Up to 12 weeks

  • Heart rate

    Up to 12 weeks

  • Respiratory rate

    Up to 12 weeks

  • Oxygen Saturation

    Up to 12 weeks

  • +1 more secondary outcomes

Study Arms (2)

Conventional therapy

ACTIVE COMPARATOR

Exercise-based cardiac rehabilitation

Other: Exercise

Virtual reality based therapy

EXPERIMENTAL

Exercise-based virtual reality

Other: Exercise

Interventions

Both interventions uses exercises

Conventional therapyVirtual reality based therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with cardiovascular diseases
  • Patients with risk factors to develop cardiovascular diseases

You may not qualify if:

  • \- Patients who disagree to participate of any protocol interventions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laboratório de Fisiologia do Estresse

Presidente Prudente, São Paulo, 19060900, Brazil

Location

Related Publications (2)

  • da Cruz MMA, Ricci-Vitor AL, Borges GLB, da Silva PF, Turri-Silva N, Takahashi C, Grace SL, Vanderlei LCM. A Randomized, Controlled, Crossover Trial of Virtual Reality in Maintenance Cardiovascular Rehabilitation in a Low-Resource Setting: Impact on Adherence, Motivation, and Engagement. Phys Ther. 2021 May 4;101(5):pzab071. doi: 10.1093/ptj/pzab071.

  • Alves da Cruz MM, Ricci-Vitor AL, Bonini Borges GL, Fernanda da Silva P, Ribeiro F, Marques Vanderlei LC. Acute Hemodynamic Effects of Virtual Reality-Based Therapy in Patients of Cardiovascular Rehabilitation: A Cluster Randomized Crossover Trial. Arch Phys Med Rehabil. 2020 Apr;101(4):642-649. doi: 10.1016/j.apmr.2019.12.006. Epub 2020 Jan 8.

MeSH Terms

Conditions

Heart DiseasesCardiovascular DiseasesPatient Compliance

Interventions

Exercise

Condition Hierarchy (Ancestors)

Patient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Ana Laura Ricci-Vitor, PhD

    Universidade Estadual Paulista Júlio de Mesquita Filho

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

November 6, 2017

First Posted

December 19, 2017

Study Start

December 19, 2017

Primary Completion

December 1, 2018

Study Completion

June 3, 2019

Last Updated

August 5, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

After published results,

Locations